Scott Bardo serves as the Head of Medical Technology, Diagnostics and LifeScience tools EMEA at Citi. In this role, he leverages his extensive background in healthcare investment banking. His expertise encompasses corporate advisory, mergers and acquisitions (M&A), equity capital markets (ECM), and equity research.

Bardo is also skilled in various investment strategies, including portfolio management, hedge funds, private equity, and asset management.